Concurrently, PD-1/PD-L1 blockade reverses T cell exhaustion within the TME, restoring cytotoxic activity, cytokine production, including IFN-γ and tumor necrosis factor-alpha (TNF-α), and tumor cell killing [93, 94]. The gene discussed is PDCD1; the disease is neoplasm.